We are live on ! Find out more
ICM

IMS Capital Management Portfolio holdings

AUM $217M
1-Year Est. Return 18.69%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+18.69%
3 Year Est. Return
+119.31%
5 Year Est. Return
+117.37%
10 Year Est. Return
+287.2%
AUM
$81.1M
AUM Growth
-$2.47M
Cap. Flow
-$4.72M
Cap. Flow %
-5.82%
Top 10 Hldgs %
25.38%
Holding
136
New
7
Increased
37
Reduced
54
Closed
15

Top Buys

Rank Stock Value
1
WY icon
Weyerhaeuser
WY
+$863K
2
MU icon
Micron Technology
MU
+$759K
3
GILD icon
Gilead Sciences
GILD
+$756K
4
GNW icon
Genworth Financial
GNW
+$755K
5
YUM icon
Yum! Brands
YUM
+$739K

Top Sells

Rank Stock Value
1
DHI icon
D.R. Horton
DHI
+$1.16M
2
PETS icon
PetMed Express
PETS
+$1.02M
3
WFM
Whole Foods Market Inc
WFM
+$1.02M
4
FNFG
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
+$980K
5
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$809K

Sector Composition

Rank Sector Weight
1 Financials 16.91%
2 Healthcare 16.21%
3 Consumer Discretionary 15.79%
4 Technology 10.95%
5 Energy 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$618B
$1.05M 1.3%
10,261
-262
-2% -$26.3K
UNP icon
27
Union Pacific
UNP
$174B
$1.03M 1.27%
13,130
+1,236
+10% +$106K
PYPL icon
28
PayPal
PYPL
$48.9B
$998K 1.23%
27,580
-350
-1% -$12.3K
BAC icon
29
Bank of America
BAC
$435B
$996K 1.23%
59,165
+36,131
+157% +$611K
VZ icon
30
Verizon
VZ
$195B
$969K 1.2%
20,957
-584
-3% -$26.5K
MRK icon
31
Merck
MRK
$322B
$952K 1.17%
18,898
-372
-2% -$18.8K
THC icon
32
Tenet Healthcare
THC
$20.5B
$934K 1.15%
30,830
+13,550
+78% +$444K
IWP icon
33
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$908K 1.12%
19,758
-322
-2% -$15K
FDX icon
34
FedEx
FDX
$72.7B
$896K 1.11%
6,017
+27
+0.5% +$4.18K
OXY icon
35
Occidental Petroleum
OXY
$56.8B
$870K 1.07%
12,883
-945
-7% -$68K
WY icon
36
Weyerhaeuser
WY
$18B
$858K 1.06%
+28,614
New +$863K
APA icon
37
APA Corp
APA
$13.2B
$821K 1.01%
18,457
+288
+2% +$13.4K
LNC icon
38
Lincoln National
LNC
$8.73B
$816K 1.01%
16,240
-668
-4% -$35K
IDXX icon
39
Idexx Laboratories
IDXX
$44.1B
$781K 0.96%
10,710
– –
OPK icon
40
Opko Health
OPK
$985M
$763K 0.94%
75,963
+1,207
+2% +$12.1K
SLB icon
41
SLB Ltd
SLB
$73.6B
$752K 0.93%
10,788
+285
+3% +$21.3K
ZBH icon
42
Zimmer Biomet
ZBH
$18.2B
$748K 0.92%
7,506
– –
PDCO
43
DELISTED
Patterson Companies, Inc.
PDCO
$728K 0.9%
16,114
-8,610
-35% -$396K
EOG icon
44
EOG Resources
EOG
$79.2B
$726K 0.9%
10,254
+316
+3% +$25.6K
S
45
DELISTED
Sprint Corporation
S
$698K 0.86%
192,686
+6,155
+3% +$25.3K
EW icon
46
Edwards Lifesciences
EW
$49.6B
$695K 0.86%
26,400
-240
-0.9% -$6.23K
MU icon
47
Micron Technology
MU
$930B
$673K 0.83%
+47,500
New +$759K
ABBV icon
48
AbbVie
ABBV
$443B
$643K 0.79%
10,861
+136
+1% +$7.83K
QCOM icon
49
Qualcomm
QCOM
$155B
$617K 0.76%
12,335
+362
+3% +$19.3K
GNW icon
50
Genworth Financial
GNW
$3.76B
$609K 0.75%
+163,200
New +$755K
1
2
3 4 5

Similar funds

DSN
D. Scott Neal Lexington, Kentucky $216M AUM 33.28% 1-Year Est. Return
FFAM
Forge First Asset Management Toronto, Ontario, Canada $218M AUM 29.22% 1-Year Est. Return
MS
Marshall & Sullivan Seattle, Washington $216M AUM 12.97% 1-Year Est. Return
NWM
Napa Wealth Management Napa, California $213M AUM 25.01% 1-Year Est. Return
LA
Lindenwold Advisors Reading, Pennsylvania $212M AUM 13.02% 1-Year Est. Return
SNWA
Siligmueller & Norvid Wealth Advisors Glen Ellyn, Illinois $222M AUM 10.94% 1-Year Est. Return
APC
Asset Planning Corporation Knoxville, Tennessee $211M AUM 7.33% 1-Year Est. Return
WTFG
Wells Trecaso Financial Group Akron, Ohio $210M AUM 21.47% 1-Year Est. Return

IMS Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, IMS Capital Management held 136 positions worth $81.1M, down 3% from $83.5M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

IMS Capital Management withdrew a net $4.72M in Q4 2015, closing 15 positions and reducing 54 holdings. Its most notable exit was D.R. Horton, an estimated $1.16M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, IMS Capital Management opened a new position in Weyerhaeuser worth $858K.

  • IMS Capital Management's largest Q4 2015 buy was Weyerhaeuser: 28,614 shares worth $858K.
  • IMS Capital Management added most to Gilead Sciences in Q4 2015, an estimated $756K increase.
  • IMS Capital Management's biggest Q4 2015 reduction was PetMed Express, cutting an estimated $1.02M.
  • IMS Capital Management fully exited D.R. Horton in Q4 2015, selling an estimated $1.16M.
  • IMS Capital Management's ten largest holdings make up 25% of its $81.1M portfolio in Q4 2015.
  • IMS Capital Management opened 7 new positions and closed 15 in Q4 2015.
  • IMS Capital Management's portfolio value fell 3% quarter-over-quarter to $81.1M.

Based on IMS Capital Management's 13F filing for Q4 2015, filed 14 Jan 2016.